Related Experiment Video
Updated: May 7, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Community insights into type 1 diabetes care in Armenia: a qualitative study informing health policy reform
Alec Ohanian1,2, Varak Ghazarian3, Karine Mkhitaryan4
1Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA aohanian@mgb.org.
Objectives:
To explore the lived experiences of children with type 1 diabetes (T1D) and their caregivers in Armenia, a post-Soviet country, and to identify system-level barriers to care from the community perspective.
Design:
Qualitative study using a phenomenological design with inductive thematic analysis.
Setting:
Muratsan Hospital Complex, the primary national referral centre for paediatric endocrinology, Yerevan, Armenia.
Participants:
12 children aged 13-17 years with T1D and their caregivers, recruited through purposive sampling across 7 of Armenia's 10 administrative regions.
Results:
Five themes emerged from the data: (1) barriers to care, (2) quality of care, (3) perceived control of T1D, (4) knowledge of T1D and (5) government and non-governmental organisation (NGO) support. Participants described unreliable government-supplied glucose strips, geographical barriers rooted in the centralisation of specialist care in the capital, abrupt withdrawal of state support at age 18, reliance on the KATIL NGO to fill gaps in both clinical and psychosocial support and pervasive stigma encountered across family, school and clinical settings.
Conclusions:
Children with T1D in Armenia navigate a post-Soviet health system where provisions exist but remain fragmented, limited by centralised care, geographical barriers and variable support. This unique context shapes the relationship and expectations patients have of the healthcare system. Community perspectives are indispensable in these settings, surfacing system-level gaps that conventional data cannot capture. These findings have relevance for other health systems navigating similar structural transitions.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes I: Introduction
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...

